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Abstract
Background: Fermented wheat germ extract (FWGE) sold under the trade name Avemar exhibits anticancer
activity in vitro and in vivo. Its mechanisms of action are divided into antiproliferative and antimetabolic effects.
Its influcence on cancer cell metabolism needs further investigation. One objective of this study, therefore, was to
further elucidate the antimetabolic action of FWGE. The anticancer compound 2,6-dimethoxy-1,4-benzoquinone
(DMBQ) is the major bioactive compound in FWGE and is probably responsible for its anticancer activity. The
second objective of this study was to compare the antiproliferative properties in vitro of FWGE and the DMBQ
compound.
Methods: The IC50 values of FWGE were determined for nine human cancer cell lines after 24 h of culture. The
DMBQ compound was used at a concentration of 24 μmol/l, which is equal to the molar concentration of DMBQ in
FWGE. Cell viability, cell cycle, cellular redox state, glucose consumption, lactic acid production, cellular ATP levels,
and the NADH/NAD+ ratio were measured.
Results: The mean IC50 value of FWGE for the nine human cancer cell lines tested was 10 mg/ml. Both FWGE
(10 mg/ml) and the DMBQ compound (24 μmol/l) induced massive cell damage within 24 h after starting
treatment, with changes in the cellular redox state secondary to formation of intracellular reactive oxygen species.
Unlike the DMBQ compound, which was only cytotoxic, FWGE exhibited cytostatic and growth delay effects in
addition to cytotoxicity. Both cytostatic and growth delay effects were linked to impaired glucose utilization which
influenced the cell cycle, cellular ATP levels, and the NADH/NAD+ ratio. The growth delay effect in response to
FWGE treatment led to induction of autophagy.
Conclusions: FWGE and the DMBQ compound both induced oxidative stress-promoted cytotoxicity. In addition,
FWGE exhibited cytostatic and growth delay effects associated with impaired glucose utilization which led to
autophagy, a possible previously unknown mechanism behind the influence of FWGE on cancer cell metabolism.
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Background
Fermented wheat germ extract (FWGE) with the trade
name Avemar is a licensed medical nutriment for cancer
patients [1]. The anticarcinogenic potential of FWGE
has been demonstrated in vitro and in vivo [2, 3] and
confirmed in two clinical trials: an open-label cohort trial
with 170 colorectal cancer patients [4], and a randomized
phase II trial with 46 stage III melanoma patients [5] re-
ceiving continuous supplementation of FWGE along with
standard treatment. In both trials, FWGE was found to be
beneficial in terms of overall and progression-free survival
compared to standard therapy alone.
FWGE is produced as an aqueous extract, which con-
tains the antitumor compounds 2,6-dimethoxy-1,4-
benzoquinone (DMBQ) and 2-methoxy-benzoquinone
in a concentration of approximately 400 μg/g (0.04 %)
crude extract [2]. Quinones are cyclic organic com-
pounds containing two carbonyl groups (C = O) linked
to the cyclic structure of a conjugated system. Some
clinical anti-cancer compounds, e.g. Mitomycin C,
Mitoxantran, Doxorubicin, and Daunorubicin are quinone
derivatives [6, 7]. In the 1970s, Bachur et al. described
intracellular activation of benzoquinones to free radicals
that irreversibly damage biomolecules, e.g. nucleic acids
and proteins, but the benzoquinone-mediated production
of reactive oxygen species represented the primary source
of cell damage [8]. In the mid-1980s, the team of Nobel
Prize winner Albert Szent-Györgyi examined the electro-
chemical and cytotoxic properties of benzoquinones:
they injected DMBQ into the peritoneal cavity of mice har-
boring Ehrlich ascites tumor cells and found a complete
elimination of tumor cells [9].
Reactive oxygen species (ROS) represent a broad range
of chemically distinct reactive species of radicals with a
single unpaired electron, including the superoxide anion
radical (O2
−) and the hydroxyl radical (OH−), as well as
non-radical ROS such as hydrogen peroxide (H2O2). A
marked increase in intracellular ROS can cause oxidative
stress with irreversible cell damage [10]. Mammalian cells
contain different types of intracellular non-enzymatic and
enzymatic antioxidants, e.g. the tripeptide glutathione
[11], catalase, and DT-diaphorase that protect them from
unwanted oxidative damage [12]. DT-diaphorase plays an
important role in protecting cells against endogenous and
exogenous quinones [13].
FWGE influences the metabolism of cancer cells [14]
which utilize glucose in a way distinct from normal cells
[15]. A better understanding of how FWGE influences
cancer cell metabolism could improve our understanding
of its anticancer activity. The first objective of the present
study was to further elucidate the antimetabolic properties
of FWGE in cancer cells. The anticancer compound
DMBQ appears to be the bioactive molecule in FWGE
responsible for its antiproliferative and antimetabolic
properties [2]. This assumption has not yet been con-
firmed experimentally. The second objective of this
study, therefore, was to compare the antiproliferative
properties of FWGE and the DMBQ compound (at a




Human malignant cell lines (Table 1) were routinely
cultured in RPMI 1640 medium at 37 °C and 5 %
CO2 supplemented with 10 % (v/v) heat-inactivated
fetal calf serum (FCS), 100 U/ml penicillin, 100 μg/ml
streptomycin, 2 mmol/l glutamine, 50 mmol/l mercap-
toethanol, and 1 % non-essential amino acids in final
concentrations (Invitrogen Life Technologies GmbH,
Karlsruhe, Germany).
Drugs and chemicals
FWGE powder from Biropharma, Hungary, was used.
For each experiment, a fresh stock solution containing
100 mg/ml FWGE was prepared with RPMI 1640
medium and passed through a 0.2 μm filter. FWG con-
tains benzoquinones in a concentration of approx.
400 μg/g (0.04 %) crude extract as described previously
[2]. The antitumor compound DMBQ (molecular weight:
168 g/mol) at 97 % purity (Sigma-Aldrich, Germany) was
used in the same molar concentration of 24 μmol/l as
described for FWGE (Avemar) [2]. The DMBQ con-
centration for 10 mg/ml FWGE (=24 μmol/l) was cal-
culated as follows: [10 mg/ml (10 g/l) x 0.04 %]/
Table 1 IC50 values of FWGE for different human cancer cell lines.
IC50 values in mg/ml are shown as mean ± standard deviation
(SD) of three independent experiments, each performed in
triplicate and calculated as described [21]. Cancer cells were
treated for 24 h with different concentrations of FWGE (0.1, 1.0, 10,
50 mg/ml) in medium with 10 % (v/v) fetal calf serum (FCS) and
cell viability was determined by crystal violet (CV)
Cell line Tissue Mean SD
MDA-MB-468a Adenocarcinoma of the breast [33] 3.8 1.77
ASPC-1b Adenocarcinoma of the pancreas [34] 4.0 0.37
BxPC-3b Adenocarcinoma of the pancreas [34] 4.4 0.66
MDA-MB-231a Adenocarcinoma of the breast [33] 5.5 0.08
23132/87b Adenocarcinoma of the stomach [35] 7.9 2.05
HT-29a Adenocarcinoma of the colon [36] 10.9 6.36
BT-20c Adenocarcinoma of the breast [37] 13.3 7.41
HRT-18b Adenocarcinoma of the colon [38] 15.8 7.83
MCF-7a Invasive breast ductal carcinoma [37] 19.3 17.66
Cell sources: aCLS: Cell Lines Services GmbH, Eppelheim, Germany
(www.clsgmbh.de); bIOP: Institute of Pathology, University of Würzburg,
Germany. cDOG: Department of Obstetrics and Gynaecology, University of
Würzburg Hospital, Germany
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168 g/mol. For each experiment, a fresh stock solution of
0.1 mg/ml (595 μmol/l) DMBQ was set-up in RPMI 1640
medium at 37 °C for 10 min to improve solubility. After
passing the stock solution through a 0.2 μm filter, no
DMBQ sediment was observed. A fresh and sterile stock
solution of 2.4 mmol/l ascorbic acid in RPMI 1640
medium was prepared as described [16].
Measurement of FWGE effects on cell growth
Cells (1.5×104) were seeded in 200 μl culture medium
per well into 96-well flat-bottom tissue plates (Greiner
bio-one, Germany). The next day, cells were incubated
for 24 h with fresh culture medium containing the final
concentrations of 0.1, 1.0, 10, 50 mg/ml FWGE accord-
ing to published data [17–19]. The tissue plates were
cultured at 37 °C in a humidified atmosphere of 5 %
CO2 in air and cellular viability was determined by
crystal violet (CV) staining as described previously
[20]. The absorbance (optical density, OD) was measured
with a microplate reader (MRX, Dynatech Laboratories) at
a wave length of 570 nm which is directly propor-
tional to the number of viable cells. Dose–response
curves were used to calculate IC50 values as described
[21]. After a 24 h-exposure with 10 mg/ml FWGE,
the following three antiproliferative effects (which in-
fluence the number of viable cells) were observed:
cytotoxic, cytostatic, and growth delay. By definition,
a cytotoxic effect is a reduction in initial viable cell
count >15 %, a cytostatic effect a change in initial viable
cell count ±15 %, and delayed growth effect an increase in
initial viable cell count >15 %.
Determination of cellular ATP content and NADH/NAD+ ratio
Cellular ATP content was determined with the Colori-
metric/Fluorometric Assay Kit (K354-100) from BioVi-
sion, USA according to the manufacturer’s instructions.
ATP content was given in pg/106 cells for 24 h. The
NADH/NAD+ ratio, determined with the quantitation
colorimetric kit (K337-100) from BioVision, was given
for 104 cells.
Measuring cellular redox state
The OxiSelect™ lntracellular ROS Assay Kit (Gell Biolabs,
USA; STA-342) is a cell-based assay for measuring
the activity of hydroxyl, peroxyl, and other reactive
oxygen species within a cell. The assay employs the
redox-sensitive fluorogenic dye DCFH-DA, which diffuses
into cells and is deacetylcated by cellular esterases into the
non-fluorescent DCFH. ln the presence of ROS, DCFH is
rapidly oxidized to highly fluorescent DCF. Fluorescence
was quantified 12 h and 24 h after incubation with FWGE
and DMBQ on a standard fluorescence plate reader at
480/530 nm. Results are presented as relative fluorescence
units normalized for 104 cells.
Glucose consumption and lactic acid production
Cells (1.5×104) were seeded in 200 μl culture medium
per well into 96-well flat-bottom tissue plates (Greiner
bio-one). After 24 h, 48 h, and 72 h of culture, cell-free
supernatant was analyzed for glucose consumption and
lactic acid production by the central laboratory of the
University Hospital of Würzburg using the Cobas 8000
modular analyzer series (Roche Diagnostics, Germany).
Glucose consumption was calculated from the difference
between glucose concentration in cellfree control medium
and glucose concentration remaining in the supernatant of
cell cultures after incubation. Lactic acid production was
calculated from the difference between lactic acid concen-
trations in the supernatant of cell cultures before and after
incubation. Results were correlated to the cell count and
displayed as consumption/production per 104 cells.
Western blotting
Western blotting was performed as described earlier
[22, 23]. ln brief, 1 × 106 cells each were lysed in pre-
cooled RIPA buffer (Pierce, USA) containing phosphatase
and proteinase inhibitors and 2.5 mmol/l dithiothreitol
(Sigma-Aldrich). Equal amounts of proteins (30 μg) were
loaded on a 10 % polyacrylamide gel (SDS-PAGE),
electrophoresed, and then blotted by semi-dry transfer
onto a nitrocellulose membrane (Schleicher & Schuell,
Germany). After a blocking step with 5 % non-fat milk
(Merck, Germany), membranes were incubated with either
a rabbit anti-DT diaphorase primary antibody (NQ01,
N5288, Sigma-Aldrich; diluted 1:2,000) or a rabbit anti-
LC3-I/-II primary antibody (AHP2167T; AbD Serotec
GmbH, Germany; diluted 1:1,000). After washing with
phosphate buffered saline (PBS), membranes were incu-
bated with a horseradish peroxidaseconjugated goat anti-
rabbit secondary antibody (KPL, USA; diluted 1:10,000) for
60 min at room temperature. A monoclonal mouse anti-β-
actin primary antibody (Abcam, UK; diluted 1:10,000) was
used as loading control and visualized with the goat anti-
mouse secondary antibody (KPL, diluted 1: 10,000). lmmu-
noblots were visualized by enhanced chemiluminescence
western blotting substrate (Pierce, Thermo Scientific, USA)
with subsequent exposure on an X-ray film (Fuji Super RX
medical X-ray films; Fuji, Germany) for 30 s.
Cell cycle analysis
For cell cycle analysis, 1×106 cells were fixed in suspen-
sion with 70 % ice-cold ethanol (−20 °C) and incubated
for 2 h at 4 °C. Subsequently, ice-cold PBS was added
and the cells were pelleted at 250 xg for 6 min at 4 °C.
Cell pellets were resuspended with PBS. RNase (lnvitro-
gen GmbH, Germnay) was added for a final concentra-
tion of 50 μg/ml and incubated at 37 °C for 30 min in
the dark. Then propidium iodide (Sigma-Aldrich; stock
solution: 1 mg/ml, final concentration: 50 μg/ml) was
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added. After 5 min of incubation, the cells were mea-
sured for their DNA amount with a FACScan (Becton
Dickinson, Germany). Data (10,000 events per acquisi-
tion) were recorded with BD CellQuest™ Pro software
(Version 5.1.1) and data were analyzed with WinMDI
software (Version 2.9).
Statistical analysis
The experiments were performed at least three times
with triplicate samples. The means were compared using
analysis of variance (ANOVA) plus Bonferroni’s t-test. A
P-value of <0.05 was considered to indicate a statistically
significant result.
Results
Antiproliferative properties of FWGE
The mean IC50 value of FWGE determined for nine can-
cer cell lines tested after 24 h of culture was 10 mg/ml
(range from 3.8 to 19.3 mg/ml) (Table 1). The pancreatic
cancer cell lines BxPC-3 and ASPC-1 and breast cancer
cell lines MDA-MB-468 and MDA-MB-231 were ex-
tremely sensitive to FWGE with IC50 values ranging
from 3.8 ± 1.77 to 5.5 ± 0.08 mg/ml. FWGE had less ef-
fect on the viability of MCF-7 cells (19.3 ± 17.66 mg/ml),
which were the most insensitive cells to FWGE tested in
this study. The calculation of Kendall's tau-b rank cor-
relation coefficient displayed a strong correlation be-
tween the EC50 values of the cell lines tested and the
antiproliferative properties of FWGE (r = 0.545, P < 0.05).
In cell lines with IC50 < 6.0 mg/ml, FWGE usually trig-
gered cytotoxic effects, in cell lines with IC50 > 6.0 mg/ml,
FWGE usually triggered cytostatic effects.
Characterization of the antiproliferative effect of the
mean IC50 value of 10 mg/ml FWGE after 24 h treat-
ment of the nine cancer cell lines revealed a cytotoxic ef-
fect in four cell lines (ASPC-1, BxPC3, MDA-MB-231,
MDA-MB-468), a cytostatic effect in four cell lines
(23132/87, BT-20, HT-29, MCF-7) and a growth delay
effect in HRT-18 cells (Additional file 1: Figure S1 and
Fig. 1a). FWGE at a concentration of 1 mg/ml had no
effect on cell viability and 50 mg/ml was cytotoxic for all
nine cell lines after a 24 h treatment (not shown). A
concentration of 10 mg/ml FWGE has been reported to
induce biological responses in normal peripheral blood
lymphocytes in vitro [18]. Therefore, we did not use
concentrations >10 mg/ml FWGE to analyze its antipro-
liferative effects.
Antiproliferative properties of FWGE and DMBQ
One cell line each was selected to investigate the three
antiproliferative properties of FWGE: BxPC-3 cells (cyto-
toxic effect), 23132/87 cells (cytostatic effect) and HRT-
18 cells (growth delay effect). The DMBQ compound
was used in a concentration of 24 μmol/l, which is equal
to its concentration in FWGE. At this concentration, the
DMBQ compound induced strong cytotoxicity in all
nine cancer cell lines tested after 24 h of treatment. Rep-
resentative results for the three cell lines BxPC-3,
23132/87 and HRT-18 are shown in Fig. 1a, results for
other cell lines in the Additional file 1: Figure S1. BxPC3
cells reacted very sensitively to treatment with FWGE
and DMBQ. The cytotoxicity induced by DMBQ-
mediated ROS is well known [8, 9]. We found that the
massive cell damage induced by the DMBQ compound
and FWGE was linked to aberrant levels of intracellular
DCF fluorescence. This shift in the cellular redox state
was caused by intracellular ROS (Fig. 1b) and was con-
firmed by experiments with exogenous glutathione
(Additional file 2: Figure S2). Exogenous glutathione
(GSH) protected BxPC-3 cells against DMBQ compound/
FWGE-induced cell damage, confirming the oxidative-
type cytotoxicity of DMBQ and FWGE. The strong cyto-
toxic effect of FWGE and the DMBQ compound in
BxPC-3 cells was linked to a loss of the enzyme DT-
diaphorase (Additional file 3: Figure S3) which protects
cells against benzoquinone-induced oxidative stress. The
FWGE-induced cytostatic and growth delay effects in
23132/87 and HRT-18 cells were linked to moderate ROS
levels (Fig. 1b). In contrast to its cytotoxic effect, FWGE’s
cytostatic and growth delay effects were not influenced by
GSH (Additional file 2: Figure S2).
Metabolic effects of FWGE
The cytostatic and growth delay effects of FWGE in
23132/87 and HRT-18 cells indicate that it influences
cell metabolism and function. We found that the
FWGE-induced cytostatic effect in 23132/87 cells is
based on cell cycle arrest (Additional file 4: Figure S4).
In addition, we found that the FWGE-induced cytostatic
effect in 23132/87 cells was linked to impaired glucose
consumption and significantly reduced production of
lactic acid (P < 0.01, Fig. 2a,c). In HRT-18 cells, the
growth delay effect of FWGE was also linked to im-
paired glucose consumption and the cells produced less
lactic acid (Fig. 2b,d). However, in comparison to un-
treated HRT-18 cells, it was obvious that FWGE-treated
HRT-18 cells produced more lactic acid than expected
based on overall glucose consumption after 48 and 72 h
of culture (Fig. 2b,d). At 72 h of culture, FWGE-treated
HRT-18 cells consumed four-fold less glucose than
FWGE-untreated cells but produced the same levels of
lactic acid, indicating that HRT-18 cells are able to shift
their metabolism to other energy sources than glucose
linked with production of lactic acid, e.g. glutamine via
glutaminolysis.
Impaired glucose consumption can affect cellular
energy sources. We therefore measured cellular ATP and
NADH levels in 23132/87 and HRT-18 cells. FWGE-
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treated 23132/87 cells exhibited a 66 % depletion in cellu-
lar ATP and a 60 % decrease in the NADH/NAD+ ratio
(Fig. 2e). In HRT-18 cells, FWGE also decreased the
NADH/NAD+ ratio by 64 % (Fig. 2f) with unchanged cel-
lular ATP content. The decrease in the NADH/NAD+ ra-
tio, reflecting an increase in the amount of (non-reduced)
NAD+, indicates that FWGE influenced the reduction of
the NAD+ pool in these cells.
FWGE-induced autophagy
The unchanged ATP content in FWGE-treated HRT-18
cells (Fig. 2f) was linked to growth delay (Fig. 1) with pro-
longed cell survival in continuous culture with FWGE
(Fig. 3). Microscopic analysis of FWGE-treated HRT-18
cells demonstrated the formation of intracellular vacuoles,
first observed 24 h after starting incubation, which
increased in size with increasing incubation time (Fig. 4).
To determine whether the FWGE-induced formation of
intracellular vacuoles was a characteristic sign of au-
tophagy, a pro-survival self-degradation process under
metabolic stress, we analyzed the cells for the presence
of the autophagy marker LC3-II. With an anti-LC3
antibody, we confirmed the presence of LC3-II exclu-
sively in FWGE-treated HRT-18 cells (Fig. 4). This indi-
cates an accumulation of HRT-18 cells within the cell
population demonstrating autophagic activity during
incubation with FWGE.
Discussion
ln this study we analyzed the antiproliferative and anti-
metabolic effects of fermented wheat germ (FWGE) sold
under the trade name Avemar. Because FWGE contains
the anticancer compound DMBQ, which is thought to
be responsible for the antiproliferative and antimetabolic
properties of FWGE [2], we investigated whether FWGE
and DMBQ exhibit similar antiproliferative effects. For

















































































































Fig. 1 Antiproliferative properties of FWGE and DMBQ. The effects of FWGE (mean IC50: 10 mg/ml) and DMBQ (24 μmol/l; equal to the DMBQ
concentration in FWGE) on cancer cell viability (a). Intracellular DCF fluorescence signals indicating intracellular ROS formation after 12 h (BxPC-3
cells) and 24 h (23132/87 and HRT-18 cells) of culture (b). The dashed line indicates the relative initial cell count at the start of treatment. For this,
the seeded cells were stained with crystal violet directly after their adherence and the absorbance was normalized to 100 %. By definition, a
cytotoxic effect was a reduction in initial viable cell count >15 %, a cytostatic effect a change in initial cell count of ±15 %, and a delayed growth
effect an increase in the initial cell count >15 %. Ascorbic acid (2.4 mmol/l) was used to activate DMBQ [16]. Ascorbic acid had no influence on
cancer cell viability or FWGE (not shown). Results are shown as mean ± standard deviation and representative for at least three independent
experiments performed in triplicate. **P < 0.01, ***P < 0.001 in comparison to untreated control cells. RFU, relative fluorescence units
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this purpose, the DMBQ compound was used in a molar
concentration of 24 μmol/l equal to its concentration in
FWGE [2, 3]. FWGE and DMBQ were tested on nine
human cancer cell lines derived from different cancer
types (Table 1). ln addition, the effect of Avemar was
also tested on normal human dermal fibroblasts (Promo-
Cell, Germany) with an IC50 value of 35.5 ± 20.5 mg/ml
(not shown). 24 μmol/l of the DMBQ compound was
found to be cytotoxic for all cancer cell lines tested
within 24 h (Additional file 1: Figure S1), whereas
10 mg/ml FWGE (mean IC50 value) exhibited additional
cytostatic and growth delay effects. In this context, it
is worth mentioning that 10 mg/ml FWGE in con-
tinuous culture with cancer cells was cytotoxic (Fig. 3),
as was 50 mg/ml FWGE for 24 h (not shown). The
treatment of cells with 10 mg/ml FWGE for 24 h
allowed us to investigate the antimetabolic mechanisms of
FWGE in detail.
DMBQ-mediated ROS-induced cytotoxicity is well
known [8, 9, 24, 25]. We found that DMBQ-induced cell
damage was linked to increased intracellular DCF fluor-
escence. A comparable increase in DCF fluorescence
was also found in BXPC-3 cells incubated with FWGE
and indicates the production of intracellular ROS. De-
tection of ROS based on DCF fluorescence is the most
widely used assay but various caveats apply [26]. Our
present findings provide further evidence for DMBQ/
FWGE-induced ROS production, showing that exogen-
ous glutathione (GSH) protected BxPC3 cells against
DMBQ/FWGE-induced cell damage. Cellular glutathi-
one levels are maintained by de novo synthesis, reduc-






































































































































































































Fig. 2 FWGE-influenced cancer cell metabolism. Lactic acid production (mmol/l for 104 cells) and glucose consumption (mmol/l for 104 cells) by
23132/87 cells (a, c) and HRT-18 cells (b, d) with and without FWGE treatment for the incubation times indicated. Cellular ATP content (pg/106 cells)
and the NADH/NAD+ ratio in 23132/87 cells (e) and HRT-18 cells (f) with and without FWGE treatment after 24 h of culture. Results are shown as
mean ± standard deviation for three independent experiments.***P < 0.001 to FWGE-untreated cells
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from exogenous sources [11], underlining the role of
glutathione as a free radical scavenger in cell cultures as
described elsewhere [25]. In addition, the thiolic antioxi-
dant N-acetylcysteine and catalase both displayed protect-
ive effects and prevented DMBQ/FWGE-induced cell
damage (not shown). In contrast to its cytotoxic effect, the
cytostatic and growth delay effects of FWGE appear to be
independent of oxidative stress and glutathione had no
observable effect on cell viability.
A review of the literature shows that intracellular fla-
voenzymes play an important role in quinone bioactiva-
tion [25]. In addition, activation of DMBQ outside the
cell with ROS-induced lipid peroxidation is described as
a possible mechanism for quinone cytotoxicity [25, 27].
The barrier function of the plasma membrane is lost and
DMBQ diffuses through the open plasma membrane
into the cytoplasm with intracellular ROS production.
With the exception of BxPC3 and ASPC-1 cells, DMBQ
showed a need for ascorbic acid in order to induce
DMBQ-mediated ROS production. Ascorbic acid acts as
electron donor and reduces DMBQ to semiquinone radi-
cals [9]. It can be transported across the plasma membrane
into the cell via the sodium-dependent vitamin C trans-
porter or, in its oxidized form, via glucose transporter, in-
cluding the ubiquitously expressed Glut1 [28]. In contrast
to DMBQ, the antiproliferative effect of FWGE was not in-
fluenced by ascorbic acid (not shown).
Some of the mechanisms of action for FWGE can be
classified as metabolic effects [14]. For example, FWGE
prevents glucose uptake into cells and inhibits key
enzymes of glycolysis such as hexokinase and lactate
dehydrogenase [17, 18]. Under sufficient oxygenation, nor-
mal cells direct glucose predominantly to mitochondrial
oxidative phosphorylation to generate ATP, while cancer
cells often exhibit nonoxidative glucose utilization, which
enhances lactic acid production by lactate dehydrogenase
(LDH). The reaction of LDH leads to the oxidization of
NADH to NAD+, necessary to support glycolytic flux [15].
The exact role and regulation of a hyperactivated
glycolytic pathway in cancer cells, termed aerobic gly-
colysis or the Warburg effect, is still not fully under-
stood. Its major benefit to cancer cells is rapid ATP
production and increased supply with anabolic sub-
strates [29]. To determine FWGE-induced alterations
in cancer cell metabolism, we measured glucose consump-
tion and generation of lactic acid during cell culture.
FWGE impaired glucose consumption of 23132/87 cells
and HRT-18 cells caused a low NADH/NAD+ ratio, an
indication of decreased glucose flux through glycolysis.
In contrast to 23132/87 cells, FWGE-treated HRT-18
cells formed more lactic acid than would be expected
from the low glucose consumption. An alternative
pathway for the generation of lactic acid independent



























Fig. 3 Viability of HRT-18 and 23132/87 cells continuously cultured with FWGE. Incubation of 23132/87 and HRT-18 cells with 10 mg/ml FWGE
was cytotoxic after 72 h of continuous culture for 23132/87 cells and after 120 h for HRT-18 cells. Cells were incubated in medium with 10 %
(v/v) fetal calf serum and cell viability was determined by crystal violet staining at the culture times indicated. The dashed line indicates the relative
initial cell count at the start of treatment. For this, the seeded cells were stained with crystal violet directly after their adherence and the absorbance
was normalized to 100 %. By definition, a cytotoxic effect was a reduction in initial viable cell count >15 %, a cytostatic effect a change in initial cell
count ±15 % and a delayed growth effect an increase in the initial cell count >15 %. Results are shown as mean ± standard deviation for three
independent experiments, each performed in triplicate for each time point. ***P < 0.001 in comparison to 24 h
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involved in the conversion of cytosolic malic acid into
pyruvic acid by malic enzymes [30], where excess pyru-
vic acid is then depleted by LDH. The impact of glu-
tamine on formation of lactic acid independent of
glycolysis by FWGE-treated HRT-18 cells was not an
object of this study and will be addressed in further
studies.
FWGE-treated HRT-18 cells exhibited autophagic ac-
tivity as demonstrated by the presence of the autophagy
marker LC3-II [31]. Autophagy is a self-degradation
process which is proposed to have a pro-survival effect
for cancer cells under metabolic stress by shifting the
energy production from glycolysis towards degradation
of unneeded proteins and fatty acids to feed the citric
acid cycle for generating ATP [32]. In this context, we
found unchanged ATP levels in FWGE-treated HRT-18
cells, indicating that they are able to compensate the
impaired glucose utilization during incubation with
FWGE and maintain glycolysis-independent ATP pro-
duction. In addition, HRT-18 cells had prolonged cell
survival during continuous culture with FWGE in com-
parison to 23132/87 cells, which did not exhibit au-
tophagy (Fig. 3). Taken together, the antiproliferative
properties of FWGE display a complex interaction with
cancer cell metabolism.
Conclusions
The antiproliferative properties of FWGE are complex
and differ in some respects from those of the DMBQ
compound. This may explain why there is to date no evi-
dence of toxic side effects from FWGE in clinical trials in
contrast to clinically applied quinone compounds. In
addition to its cytotoxic effect, FWGE also has cytostatic
and growth delay effects at a concentration of 10 mg/ml
after 24 h of incubation, while 24 μmol/l of the DMBQ
compound (equal to the DMBQ concentration in FWGE)
was uniformly cytotoxic for all cancer cell lines we tested.
The oxidative cell damage potential of activated DMBQ
was confirmed by aberrant intracellular DCF fluorescence,
indicating increased levels of intracellular ROS. A marked
increase of ROS was also found to underlie the cytotoxic
effect of FWGE. Moderate levels of intracellular ROS were
found to underlie the cytostatic and growth delay effects of
FWGE which were linked to impaired glucose utilization
and induction of autophagy, a previously unknown mech-
anism of FWGE for targeting cancer cell metabolism.
Fig. 4 FWGE-induced autophagic activity in the colon carcinoma cell line HRT-18. FWGE-treated HRT-18 cells showing intracellular vacuoles 24 h
after start of incubation. The vacuoles increased in size with increasing incubation time (a). Presence of endogenous LC3-II in HRT-18 cells with
and without FWGE treatment at different incubation times (b). LC3-I (approximately 17 kDa) is the cytosolic form of LC3, which is converted into
the active, membrane-bound form LC3-II (approximately 14–15 kDa) during the autophagy process. β-actin was used as a loading control (42 kDa).
The shift from LC3-I to LC3-II is evident following FWGE treatment. Western blot results are shown for one trial representative of three independent
experiments (c). The LC3-II/LC3-I ratio was calculated based on densitometry analysis (ImageJ 1.3.4 s downloaded from the National Institutes of Health
(NIH), Bethesda, MD, USA) of LC3-I and LC3-II bands for three independent experiments (***P < 0.001, *P < 0.05 in comparison to FWEG-untreated cells)
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Additional files
Additional file 1: Figure S1. Antiproliferative properties of FWGE and
DMBQ on cancer cells. 10 mg/ml FWGE exhibited cytotoxic (a) and
cytostatic (b) effects after 24 h of culture. The growth delay effect in HRT-
18 cells is shown in Fig. 1. Representative figures of crystal violet stained
viable cancer cells treated with FWGE and DMBQ after 24 h of culture (c).
DMBQ displayed a strong cytotoxic effect in all cancer cell lines. The dashed
line indicates the relative initial cell count at the start of treatment. For this,
the seeded cells were stained with crystal violet directly after their
adherence and the absorbance was normalized to 100 %. By definition, a
cytotoxic effect was a reduction in initial viable cell count >15 %, a cytostatic
effect a change in initial cell count ±15 % and a delayed growth effect an
increase in the initial cell count >15 %. Ascorbic acid (2.4 mmol/l) was used
to activate DMBQ [16] and had no influence on cell viability or the effect of
FWGE (not shown). Results are shown as mean ± standard error of mean
(S.E.M.) and representative for at least three independent experiments
performed in triplicate. Magnification: 80x. *P < 0.05, **P < 0.01, ***P < 0.001
in comparison to untreated control cells. (PDF 216 kb)
Additional file 2: Figure S2. The protective effect of exogenous
glutathione on the viability of cancer cells treated with FWGE/DMBQ. The
protective effects of exogenous glutathione (GSH) protected against
DMBQ and FWGE-induced cytotoxicity in BxPC-3, 23132/87, and HRT-18
cells. GSH did not influence FWGE-induced cytostatic and growth delay
effects. Cancer cells were treated with FWGE (10 mg/ml) or DMBQ
(24 μmol/l) with (+) and without (−) GSH for 24 h. The GSH concentration
(3.6 mmol/l) used was optimal as determined in previous studies. The
dashed line indicates the relative initial cell count at the start of treatment.
For this, the seeded cells were stained with crystal violet directly after their
adherence and the absorbance was normalized to 100 %. Results present
the mean (±S.E.M.) of three independent experiments, each performed in
triplicate. Cancer cells were cultured in RPMI 1640 medium with 10 % (v/v)
fetal calf serum (FCS). **P < 0.01 in comparison to untreated control cells,
n.s. = not significant. (PDF 15 kb)
Additional file 3: Figure S3. Demonstration of the presence of DT-
diaphorase in cancer cells and fibroblasts. ASPC-1 and BxPC-3 cells
exhibited a complete loss of the enzyme DT-diaphorase (NAD(P)H:-
quinone oxidoreductase, NQO1), which protects cells particularly
against benzoquinone-induced oxidative stress and can explain the
sensitivity of BxPC-3 and ASPC-1 cells (not shown) to incubation with
FWGE and DMBQ. Whole cell extracts of ASPC-1, BxPC-3, 23132/87,
HRT-18 cells and normal human dermal fibroblasts (NHDF from PromoCell,
Germany) were separated on SDS-PAGE and probed with rabbit anti-DT-
diaphorase antibody, which detects a protein band of 28 kDa. A monoclonal
mouse anti-β-actin primary antibody was used as loading control (42 kDa).
(PDF 26 kb)
Additional file 4: Figure S4. Cell cycle analysis of FWGE-treated and
untreated cells. The cell cycle was analyzed 24 h after start of incubation
with FWGE (10 mg/ml). Isolated nuclei were stained with propidium
iodide (PI) and then subjected to flow cytometry analysis for their
DNA content. FACS profiles for 23132/87 cells (a) and HRT-18 cells (b).
Results are shown as mean ± S.E.M. from three different experiments. The
bar graph shows the percentages of cells in G1, S, and G2/M. *P < 0.05, n.s.,
not significant. (PDF 121 kb)
Abbreviations
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